Related Experiment Videos

Pacing in hypertrophic cardiomyopathy

P Sorajja1, P M Elliott, W J McKenna

  • 1Department of Cardiological Sciences, St. George's Hospital Medical School, London, United Kingdom.

Cardiology Clinics
|March 10, 2000
PubMed

Insights

Dual chamber pacing offers hemodynamic and symptomatic benefits for hypertrophic cardiomyopathy patients. Recent trials suggest considering a pacing trial before surgical intervention for drug-refractory symptoms.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology

Background:

  • Hypertrophic cardiomyopathy (HCM) management often involves surgery.
  • Dual chamber pacing presents a potential non-surgical alternative for HCM.
  • Previous reports indicate hemodynamic and symptomatic improvements with pacing in HCM.

Purpose of the Study:

  • To review recent clinical trial data on dual chamber pacing in hypertrophic cardiomyopathy.
  • To evaluate the efficacy of pacing as an alternative to surgery for drug-refractory HCM symptoms.

Main Methods:

  • Review of recently concluded clinical trials.
  • Analysis of studies investigating dual chamber pacing in hypertrophic cardiomyopathy patients.

Main Results:

  • Dual chamber pacing has demonstrated hemodynamic benefits in HCM patients.
  • Symptomatic improvements have been documented in patients undergoing pacing for HCM.
  • Recent trials provide further evidence supporting pacing's role in HCM management.

Conclusions:

  • Dual chamber pacing is a viable alternative to surgery for select hypertrophic cardiomyopathy patients.
  • A trial of pacing should be considered for patients with drug-refractory symptoms before surgical options.
  • Ongoing research continues to define the optimal role of pacing in hypertrophic cardiomyopathy treatment.

Related Concept Videos